|
AMGN's Net Income Growth by Quarter and Year
Amgen Inc 's Net Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
|
| AMGN Net Income (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
| IV Quarter |
December |
-
|
1,616.00
|
1,899.00
|
1,615.00
|
| III Quarter |
September |
-
|
2,143.00
|
1,884.00
|
2,021.00
|
| II Quarter |
June |
1,379.00
|
1,317.00
|
464.00
|
1,803.00
|
| I Quarter |
March |
2,841.00
|
1,476.00
|
1,646.00
|
1,825.00
|
| FY |
|
4,220.00
|
6,552.00
|
5,893.00
|
7,264.00
|
| AMGN Net Income second quarter 2023 Y/Y Growth Comment |
Amgen Inc reported Net Income growth of 4.71% year on year in the second quarter 2023, to $ 1,379.00 millions, this is lower than Amgen Inc 's recent average Net Income increase of 18.8%.
Looking into second quarter 2023 results within Biotechnology & Pharmaceuticals industry 4 other companies have achieved higher Net Income growth. While Amgen Inc ' s Net Income increase of 4.71% ranks overall at the positon no. 643 in the second quarter 2023.
|
| AMGN Net Income ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
-14.9 % |
17.59 % |
-5.17 % |
| III Quarter |
September |
- |
13.75 % |
-6.78 % |
2.69 % |
| II Quarter |
June |
4.71 % |
183.84 % |
-74.27 % |
-17.26 % |
| I Quarter |
March |
92.48 % |
-10.33 % |
-9.81 % |
-8.38 % |
| FY |
|
- |
11.18 % |
-18.87 % |
-7.37 % |
AMGN Net Income (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
-24.59 % |
0.8 % |
-20.09 % |
| III Quarter |
September |
- |
62.72 % |
306.03 % |
12.09 % |
| II Quarter |
June |
-51.46 % |
-10.77 % |
-71.81 % |
-1.21 % |
| I Quarter |
March |
75.8 % |
-22.27 % |
1.92 % |
7.16 % |
| FY (Year on Year) |
|
- |
11.18 % |
-18.87 % |
-7.37 % |
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 324.15 % |
18.8 % |
-74.37 % |
| (Dec 31 2018) |
|
(Dec 31 2017) |
|
|
| Net Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 324.15 % |
18.8 % |
-74.37 % |
| (Dec 31 2018) |
|
(Dec 31 2017) |
|
| Net Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Amgen Inc 's Q/Q Net Income Growth
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 7771.43 % |
112.93 % |
-98.6 % |
| (Sep. 30, 2006) |
|
|
| AMGN's II. Quarter Q/Q Net Income Comment |
In the II. Quarter 2023 Amgen Inc disclosed fall in Net Income from the previous quarter by -51.46% to $ 1,379.00 millions, from $ 2,841.00 millions released in the previous quarter.
When you analyse present shortcoming at the II. Quarter, you must assume, that usually II. Quarter Net Income emerge softer in contrast to the quarter before
Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Net Income quarter on quarter growth. While Amgen Inc 's Net Income growth quarter on quarter, overall rank is 1515. |
|
|
|
| Net Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 7771.43 % |
112.93 % |
-98.6 % |
| (Sep. 30, 2006) |
|
|
| AMGN's II. Quarter Q/Q Net Income Comment |
In the II. Quarter 2023 Amgen Inc reported fall in Net Income sequentially by -51.46% to $ 1,379.00 millions, from $ 2,841.00 millions achived in the previous reporting period.
This is not huge concern, as Amgen Inc 's Net Income frequently gravitate to dip in the II. Quarter.
Within Biotechnology & Pharmaceuticals industry 7 other companies have achieved higher Net Income quarter on quarter growth. While Amgen Inc 's Net Income growth quarter on quarter, overall rank is 1515. |
|
Amgen Inc 's 12 Months Net Income Growth Year on Year
Net Income TTM Growth |
12 Months Ending
(Jun 30 2023) |
12 Months Ending
(Mar 31 2023) |
12 Months Ending
(Dec 31 2022) |
12 Months Ending
(Sep 30 2022) |
12 Months Ending
(Jun 30 2022) |
| Cumulative Net Income 12 Months Ending |
$ 7,979.00 |
$ 7,917.00 |
$ 6,552.00 |
$ 6,835.00 |
$ 6,576.00 |
| Y / Y Net Income Growth (TTM) |
21.34 % |
38.34 % |
11.18 % |
21.86 % |
14.44 % |
| Year on Year Net Income Growth Overall
Ranking |
# 739 |
# 234 |
# 1157 |
# 448 |
# 967 |
| Seqeuential Net Income Change (TTM) |
0.78 % |
20.83 % |
-4.14 % |
3.94 % |
14.9 % |
| Seq. Net Income Growth (TTM) Overall
Ranking |
# 732 |
# 184 |
# 799 |
# 514 |
# 742 |
| Cumulative Net Income growth
Comment |
Assuming the Amgen Inc 's fiscal year would have ended in Jun 30 2023, Amgen Inc would have reprted above average annual Net Income rise of 21.34% year on year, of $ 7,979 millions.
This marks a slow-down of the companys growth trends and from the 38.34% improvement in Mar 31 2023.
In the Healthcare sector 39 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 234 to 739. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
324.15 % |
18.8 % |
-74.37 % |
|
|
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
324.15 % |
18.8 % |
-74.37 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 5 |
| Sector |
# 40 |
| S&P 500 |
# 732 |
|
| Cumulative Net Income growth
Comment |
Assuming the Amgen Inc 's fiscal year would have ended in Jun 30 2023, Amgen Inc would have reprted above average annual Net Income rise of 21.34% year on year, of $ 7,979 millions.
This marks a slow-down of the companys growth trends and from the 38.34% improvement in Mar 31 2023.
In the Healthcare sector 39 other companies have achieved higher trailing twelve month Net Income growth. While Net Income growth total ranking has deteriorated compare to previous quarter from 234 to 739. |
| Net Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
324.15 % |
18.8 % |
-74.37 % |
|
|
|
| Net Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
324.15 % |
18.8 % |
-74.37 % |
|
|
|
| Net Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 5 |
| Sector |
# 40 |
| S&P 500 |
# 732 |
|
8.12%